Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
First approved to treat type 2 diabetes, GLP-1 based drugs are now used to aid weight loss in obesity and to help lower the risk of heart failure and treat obstructive sleep apnea, a common breathing-related sleep disorder, in people with obesity
For patients who cannot use GLP-1 or who do not respond well to it, alternatives include: Other GLP-1 receptor agonists like liraglutide or dulaglutide SGLT2 inhibitors or DPP-4 inhibitors for diabetes management Non-medication-based approaches like bariatric surgery for weight loss Your healthcare provider can guide you in choosing the best treatment based on your needs
With retatrutide available from research suppliers, researchers can continue to explore new therapeutic approaches and mechanisms that may ultimately help us understand human metabolism
Comprehensive review articles were referenced to identify any additional studies that were missed
